Therapy Trends: Multiple Sclerosis
Apr, 2012 · 160 pages
|
US$ 4,995.00 |
Tiered Pricing Strategies in Emerging Markets
Feb, 2012 · 93 pages
|
US$ 695.00 |
New Thinking in Patient Adherence
Mar, 2012 · 62 pages
|
US$ 695.00 |
Generic Defence Strategies: Targeting Patient Co-Pay
Mar, 2012 · 41 pages
|
US$ 695.00 |
Engaging KOLs: new thinking on thought leader development
Mar, 2012 · 58 pages
|
US$ 595.00 |
Adapting to a New Environment: Emerging Segmentation Practice in the Pharmaceutical Industry
Feb, 2012 · 43 pages
|
US$ 595.00 |
Meeting KOL Needs: What Pharma Needs to Know
Feb, 2012 · 108 pages
|
US$ 1,445.00 |
KOL Relationship Development: Leveraging Social Media Platforms
Jan, 2012 · 47 pages
|
US$ 595.00 |
Pricing and Reimbursement Trends in the US: Impact of Comparative Effectiveness Research and Cost-Effectiveness Analysis
Jan, 2012 · 85 pages
|
US$ 695.00 |
Academic Detailing: Pharma Fights Back
Jan, 2012 · 35 pages
|
US$ 745.00 |
Gauging the Biosimilar Effect: will the Market Boom or Bust?
Jan, 2012 · 42 pages
|
US$ 895.00 |
MSL-KOL Engagement: Measuring Success
Dec, 2011 · 26 pages
|
US$ 595.00 |
Interacting with KOLs: Fulfilling Current Unmet Needs
Nov, 2011 · 41 pages
|
US$ 995.00 |
iPad and Smartphone: Pharma & the Super Mobile Revolution (Customer Offer)
Nov, 2011 · 29 pages
|
US$ 195.00 |
iPad and Smartphone: Pharma & the Super Mobile Revolution
Nov, 2011 · 29 pages
|
US$ 295.00 |
Biosimilar Drugs in Europe: Threat or Opportunity to Innovation?
Nov, 2011 · 47 pages
|
US$ 595.00 |
Pharma Product Launches: Strategies for Success
Oct, 2011 · 30 pages
|
US$ 595.00 |
Payer Agreements: Splitting the Risk
Oct, 2011 · 41 pages
|
US$ 695.00 |
Health Technology Assessment (HTA): a European perspective
Oct, 2011 · 48 pages
|
US$ 995.00 |
Creating Compelling Market Access Stories
Aug, 2011 · 43 pages
|
US$ 495.00 |
Observing Patients Online: the changing face of research
Sep, 2011 · 47 pages
|
US$ 595.00 |
Pharmaceutical Brand PR: Developing Engaging Campaigns and Measuring ROI
Sep, 2011 · 62 pages
|
US$ 495.00 |
New Research into Prescribing Practices
Aug, 2011 · 43 pages
|
US$ 695.00 |
Digital Marketing Talent: Who Is Pharma hiring?
Aug, 2011 · 37 pages
|
US$ 495.00 |
The Impact of iPads on pharma: a Primer
Jul, 2011 · 33 pages
|
US$ 245.00 |
Market Access Brazil: Unlocking Pharma Potential
Jul, 2011 · 38 pages
|
US$ 795.00 |
Pharma on Twitter: Developing a Presence
Jun, 2011 · 56 pages
|
US$ 395.00 |
Pharma Blogging: Speaking Out
Mar, 2011 · 42 pages
|
US$ 495.00 |
MSL-KOL Engagement: Ensuring Compliance
Jun, 2011 · 47 pages
|
US$ 495.00 |
Market Access Europe: It's Not Just About Price
May, 2011 · 71 pages
|
US$ 795.00 |
Keys for Pharma Success: Integrating Social
May, 2011 · 51 pages
|
US$ 595.00 |
Drug Combinations: New Rules, New Opportunities
May, 2011 · 48 pages
|
US$ 895.00 |
Biosimilars Update
Apr, 2011 · 140 pages
|
US$ 695.00 |
E-detailing Trends
Mar, 2011 · 34 pages
|
US$ 495.00 |
Building Strong Market Access Teams
Feb, 2011 · 36 pages
|
US$ 395.00 |
Pharma Market Insights: Closed Loop Marketing
Feb, 2011 · 96 pages
|
US$ 695.00 |
Pharma Social Media Campaigns: Current Thinking and Future Outlook
Feb, 2011 · 51 pages
|
US$ 395.00 |
Biosimilars Regulatory Update: an Evolving Landscape
Feb, 2011 · 59 pages
|
US$ 395.00 |
Pharma Sales Force Innovations: Technology, Training and Rewards
Jan, 2011 · 36 pages
|
US$ 395.00 |
Digital Doctors: Marketing to Online Networks
Dec, 2010 · 59 pages
|
US$ 395.00 |
Pharma YouTube Channels: Content and Comment
Dec, 2010 · 81 pages
|
US$ 395.00 |
Pharma Marketing in Latin America
Nov, 2010 · 43 pages
|
US$ 395.00 |
Closing the Loop: Beyond Digital Detailing
Nov, 2010 · 48 pages
|
US$ 395.00 |
Generic Substitution: Taking a Narrow View?
Nov, 2010 · 54 pages
|
US$ 395.00 |
Biosimilars: Surveying the Market Landscape
Oct, 2010 · 75 pages
|
US$ 395.00 |
Pharma Marketing Excellence: Lessons from Experience
Aug, 2011 · 45 pages
|
US$ 595.00 |
REMS: A Standardized Approach to Risk Management
Sep, 2010 · 42 pages
|
US$ 395.00 |
Digital Technologies to Boost Patient Compliance
Sep, 2010 · 41 pages
|
US$ 395.00 |
Tomorrow’s KOLs: the Changing Face of Influence
Sep, 2010 · 49 pages
|
US$ 395.00 |
Pharma Market Insights: Generics
Sep, 2010 · 260 pages
|
US$ 1,645.00 |
